arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

XBiotech Inc.

XBIT

$2.19 0.00 (-0.23%) at close

14 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

XBiotech Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $66.8M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -39.9% ↘

FCF / Share $-1.32 ↘

Trailing P/E —

Price / Book 0.5x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$4.01M

↓ -78.2% —

Net Income Profit after all expenses

$-45.54M

↓ -18.2% —

Operating Margin Operating profit as % of sales

-136.4%

↓ -228.3% —

FCF / Share Free cash flow per share

$-1.32

↓ -24.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue Growth YoY (%)	—	—	—	-78.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1077%)	-58.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-827%)	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-18.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-55.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	25.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-86.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-61.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-18.2% Weak ↑ Weak Improving Year-over-year change in net income	-56.9% Weak ↓ Weak Declining Year-over-year change in net income	25.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-88.9% Weak Weak Year-over-year change in net income	-55.2% Weak Weak Year-over-year change in net income	N/M	N/M	36.2% Excellent ↑ Excellent Improving Year-over-year change in net income	37.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-40.8% Weak ↑ Weak Improving Year-over-year change in net income	-72.5% Weak Weak Year-over-year change in net income	-118.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-24.5% Weak ↑ Weak Improving Year-over-year change in free cash flow	-68.9% Weak Weak Year-over-year change in free cash flow	-23.9% Weak Weak Year-over-year change in free cash flow	N/M	N/M	-371.1% Weak Weak Year-over-year change in free cash flow	-2.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Operating Margin (%) (%)	—	—	—	—	-136.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1009%)	-41.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-377%)	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	31.6% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	12.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	-94.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-889%)	-25.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-313%)	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	-384.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	358.4% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-156.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-3.79x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	6.14x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-0.03x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Return on Invested Capital (%)	-39.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-40.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-44.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-70.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-76.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-37.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-3.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-47.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-54.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-78.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-35.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-32.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-316%)	-21.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	-11.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-175%)	-13.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-6.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-3.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-121%)	88.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+490%)	-51.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-440%)	-55.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-467%)	-89.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-696%)	-36.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-342%)	-36.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-345%)	-97.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-747%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Interest Coverage (x)	-114.58x Weak Weak Operating income divided by interest expense Optimal: > 5x	-106.18x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-125.55M	$-172.68M	$-200.02M	$-157.31M	$-236.98M	$-237.37M	$-714.59M	$-15.82M	$-31.77M	$-34.32M	$-91.05M	$-57.33M	$-7.24M	$-4.17M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue per Share (USD)	—	—	—	$0.13	$0.61	$1.43	$0.00	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.49	$-1.26	$-0.81	$-1.08	$-0.58	$-0.36	$17.17	$-0.59	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.32	$-1.06	$-0.63	$-0.51	$2.19	$-2.23	$-0.47	$-0.47	—	—	—	—	—	—
Book Value per Share (USD)	$4.60	$5.98	$7.19	$7.90	$8.85	$11.90	$18.20	$1.15	$1.70	$1.81	$3.19	$2.14	—	—
Tangible Book Value per Share (USD)	$4.60	$5.98	$7.19	$7.90	$8.85	$11.90	$18.20	$1.15	$1.70	$1.81	$3.19	$2.14	—	—
Basic Weighted Avg Shares (shares)	30.49M	30.46M	30.44M	30.44M	30.04M	30.82M	38.95M	35.80M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Working Capital (USD)	$119.02M	$159.46M	$195.62M	$215.78M	$243.42M	$321.89M	$656.07M	$14.07M	$30.54M	$28.97M	$86.75M	$54.92M	—	—
Total Equity (USD)	$140.35M	$182.27M	$218.85M	$240.40M	$269.38M	$348.64M	$755.63M	$41.40M	$60.16M	$59.06M	$103.05M	$59.03M	$10.23M	$7.37M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	$4.01M	$18.39M	$44.00M	$0.00	—	—	—	—	—	—	—
Depreciation Expense (USD)	$1.69M	$1.75M	$1.74M	$2.61M	$2.65M	$2.24M	$2.36M	$2.43M	$1.48M	$698.00K	$699.00K	$664.00K	$784.00K	—
Net Income, GAAP (USD)	$-45.54M	$-38.53M	$-24.56M	$-32.90M	$-17.41M	$-11.22M	$668.63M	$-21.14M	$-33.15M	$-52.76M	$-37.48M	$-21.72M	$-9.93M	—
Operating Cash Flow (USD)	$-39.92M	$-30.96M	$-18.73M	$-14.82M	$69.44M	$-65.15M	$-18.27M	$-16.54M	$-33.65M	$-46.02M	$-33.31M	$-11.70M	$-8.91M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 14 years · 52 quarters

XBiotech Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare XBIT with peers